Okairos Company

Okairos is a Swiss bio-pharmaceutical company that specializes in creating genetic T-cell vaccines for diseases such as hepatitis C. They also offer health and allied services. The company operates in Italy and was previously a subsidiary of Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa.

Estimated Revenue: €250 million
Headquarters: Basel
Industry: Gene Therapy